Polianta Ltd’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,600
Closed -$737K 104
2020
Q1
$737K Buy
+9,600
New +$737K 0.51% 56